AVaTAR Medtech logoAVaTAR Medtech logo

Medical solutions for humankind

Welcome to AVaTAR MedTech, where innovation meets compassion. Our inaugural product, AVaTAR (Aortic Valve Trileaflet Autologous Reconstruction), stands as a groundbreaking surgical method and set of medical devices designed to reconstruct the aortic or the pulmonary valve in children and adults with autologous tissue.

The Challenge

Heart diseases are the top cause of death globally

Valvular heart diseases, a subset of heart conditions, frequently involve the aortic or the pulmonary valve, which can either not open properly (stenosis), not close correctly (regurgitation/insufficiency) or suffer from the two problems.

Around 1.5% of the world's population lives with a disease affecting the aortic valve. These diseases account for 61% of all valvular heart disease deaths.
The involvement of the pulmonary valve is common in a wide variety of congenital heart diseases, such as Tetralogy of Fallot and pulmonary stenosis/atresia.
Boy in doctor's office feeling heartbeat
Our solution

A surgical method & a set of medical devices for semilunar valve reconstruction

Our cutting-edge medical devices revolutionize surgical procedures for aortic or pulmonary valve reconstruction in both children and adults. They offer a standardized, fast, and reproducible method, utilizing autologous tissue to engineer a symmetrical and functional valve.
Specifically designed for children, the innovative valve design is intentionally oversized to accommodate their growth, surpassing traditional surgical techniques and setting a new benchmark in the field.
Beneficiaries include both sick children and adults, experiencing enhanced treatment outcomes, while surgeons achieve greater efficiency in procedures with streamlined surgical processes, eliminating the need for intricate knowledge of valve geometry and functioning principles.
Closeup of surgery knives together.
The Technology

Next-Generation Medical Devices for Valve Reconstruction

The technology behind our medical devices is encapsulated in a set of surgical instruments, crafted through additive manufacturing techniques during the initial stages of development.
Anticipated to transition to mass production in its final phase, these instruments will be produced using injection molding with biocompatible plastics.
This set of medical devices provide precise assistance to surgeons, enabling the standardized creation of a valve from the patient's own tissue and its implantation in a semi-automatized fashion, ensuring sterility and efficiency of the surgical procedure through engineered single-use design.
Two surgeons in surgery

Heart Conditions Worldwide

Exploring the Prevalence and Impact of Heart Conditions Across the Globe

9.4 Million

Degenerative Aortic Valve Stenosis

It affects more than 9.4 million people worldwide, especially in developed countries.

40.5 Million

Rheumatic Heart Disease

It is the most common cause of heart valve disease and affects more than 40.5 million people worldwide, of which 2.7 million are children.

58 Million

Congenital Bicuspid Aortic Valve

Bicuspid aortic valve is the most common form of congenital heart disease, occurring in 0.71% of the general population.

1.6 Million

Aortic Regurgitation

Moderate or more severe aortic regurgitation was estimated to be prevalent in approximately 0.5% of the total US population.

1.1 Million

Infective Endocarditis

It is one of the deadliest valvular pathologies, with 1.1 million cases globally and causing 66,000 deaths annually.

1.35 Million

Children Born With Heart Defects

Representing 12 per 1,000 newborns.

50 %

of Newborns Require Surgery

50% of children born with heart defects require surgery in their first year of life.

1.3 Million

Congenital Aortic Stenosis

Children and adolescents under 18 years old suffer from congenital aortic stenosis worldwide, which comprises 4% of congenital heart defects and ranks among the top 8 most common.

Method & Device

Our procedure allows the reconstructed valve to maintain optimal functionality during the patient's cardiac structural growth.
Heart sculpture image

Available for small patients

Crafted with precision, our medical solutions are designed to cater to the unique needs of pediatric patients, ensuring optimal functionality and safety.

Enhanced Precision and Safety

Discover a revolutionary method that not only reconstructs valves perfectly and rapidly but also ensures that no part of the device remains in the patient's body, prioritizing safety and long-term well-being.

Rapid deployment

Experience the efficiency of our technology with rapid deployment, offering a swift and reliable solution for reconstructing aortic or pulmonary valves in both children and adults.

Accomodates to patient's growth

Our innovative approach allows our devices to adapt seamlessly to the natural growth of pediatric patients, providing a sustainable and effective solution over time.

Avoid anticoagulation

Say goodbye to the complications of anticoagulation. Our method ensures a safe and effective valve reconstruction without the need for ongoing anticoagulant treatments.

Boy in doctor's office feeling heartbeat

AVaTAR Pediatric

In children, treatment is complicated by the lack of suitably sized valves and rapid growth, often leading to early mortality and limited use of prosthetic valves.

Adult in the doctor's office

AVaTAR Adult

Adult treatments include valve repair/replacement and complex surgeries, but face challenges like the need for lifelong anticoagulation with mechanical valves, lower durability of biological valves, and complications in complex procedures.

Supported by


Keep up with our latest news

Explore the latest updates and advancements in medical technology, discover how AVaTAR MedTech is reshaping healthcare through innovation, and share in our commitment to progress.
Read our news